Receptor-Type Kinase Modulators and Methods of Use
The present invention provides compounds for modulating receptor kinase activity, particularly ephrin and EGFR, and methods of treating diseases mediated by receptor kinase activity utilizing the compounds and pharmaceutical compositions thereof. Diseases
-
Paragraph 0525
(2016/06/06)
IMPROVED SYNTHESIS OF DIMETHYLAMINOTHIOACETAMIDE
-
Moder, Kenneth P.,Busch, Frank R.,Richter, David C.
p. 66 - 67
(2007/10/03)
New 7-substituted quinolone antibacterial agents. The synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(2-thiazolyl and 4-thiazolyl)-3-quinolinecarboxylic acids
-
Culbertson,Domagala,Peterson,Bongers,Nichols
p. 1509 - 1520
(2007/10/02)
More Articles about upstream products of 27507-28-4